Canada
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
74.60 |
Feb. 5, 2025 | USD 0.15 | -5.56% |
|
Canada |
|
2 |
25.97 |
Feb. 5, 2025 | USD 6.23 | -0.19% |
|
Canada |
|
3 |
11.50 |
Feb. 5, 2025 | USD 9.51 | -0.80% |
|
Canada |
|
4 |
1.87 |
Feb. 5, 2025 | USD 4.39 | 2.76% |
|
Canada |
|
5 |
1.63 |
Feb. 5, 2025 | USD 4.00 | 3.39% |
|
Canada |
|
6 |
1.58 |
Feb. 5, 2025 | USD 11.31 | 1.91% |
|
Canada |
|
7 |
1.49 |
Feb. 5, 2025 | USD 2.96 | 1.10% |
|
Canada |
|
8 |
0.97 |
Feb. 5, 2025 | USD 5.33 | -0.12% |
|
Canada |
|
9 |
0.92 |
Feb. 5, 2025 | USD 64.97 | 1.17% |
|
Canada |
|
10 |
0.86 |
Feb. 5, 2025 | USD 1.52 | 2.02% |
|
Canada |
|
11 |
0.85 |
Feb. 5, 2025 | USD 125.74 | -0.23% |
|
Canada |
|
12 |
0.76 |
Feb. 5, 2025 | USD 2.65 | -1.93% |
|
Canada |
|
13 |
0.67 |
Feb. 5, 2025 | USD 7.91 | 7.55% |
|
Canada |
|
14 |
0.61 |
Feb. 5, 2025 | USD 2.82 | 1.40% |
|
Canada |
|
15 |
0.60 |
Feb. 5, 2025 | USD 11.59 | 0.75% |
|
Canada |
|
16 |
0.45 |
Feb. 5, 2025 | USD 156.50 | -0.56% |
|
Canada |
|
17 |
0.39 |
Feb. 5, 2025 | USD 3.84 | 1.43% |
|
Canada |
|
18 |
0.36 |
Feb. 5, 2025 | USD 1.59 | 1.49% |
|
Canada |
The Healthcare company in Canada with the highest Price to Sales Ratio (P/S) is Ondine Biomedical Inc. (LSE: OBI.L) at 74.60.
The Healthcare company in Canada with the lowest Price to Sales Ratio (P/S) is CareRx Corporation (Toronto Stock Exchange: CRRX.TO) at 0.36.
The top 10 Healthcare companies in Canada by Price to Sales Ratio (P/S) are Ondine Biomedical Inc., Profound Medical Corp., Cipher Pharmaceuticals Inc., WELL Health Technologies Corp., Knight Therapeutics Inc., Sienna Senior Living Inc., HLS Therapeutics Inc., dentalcorp Holdings Ltd., Metro Inc. and Theratechnologies Inc..
The bottom 10 Healthcare companies in Canada by Price to Sales Ratio (P/S) are CareRx Corporation, TELUS International (Cda) Inc., George Weston Limited, Medical Facilities Corporation, High Tide Inc., Extendicare Inc., Medexus Pharmaceuticals Inc., Loblaw Companies Limited, Theratechnologies Inc. and Metro Inc..